Details
| Stereochemistry | ABSOLUTE |
| Molecular Formula | C20H23F3N2O2 |
| Molecular Weight | 380.404 |
| Optical Activity | ( + ) |
| Defined Stereocenters | 2 / 2 |
| E/Z Centers | 0 |
| Charge | 0 |
SHOW SMILES / InChI
SMILES
COC1=CC=C(OC(F)(F)F)C=C1CN[C@H]2CCCN[C@H]2C3=CC=CC=C3
InChI
InChIKey=ZIWFCOIGUNPHPM-HKUYNNGSSA-N
InChI=1S/C20H23F3N2O2/c1-26-18-10-9-16(27-20(21,22)23)12-15(18)13-25-17-8-5-11-24-19(17)14-6-3-2-4-7-14/h2-4,6-7,9-10,12,17,19,24-25H,5,8,11,13H2,1H3/t17-,19-/m0/s1
| Molecular Formula | C20H23F3N2O2 |
| Molecular Weight | 380.404 |
| Charge | 0 |
| Count |
|
| Stereochemistry | ABSOLUTE |
| Additional Stereochemistry | No |
| Defined Stereocenters | 2 / 2 |
| E/Z Centers | 0 |
| Optical Activity | UNSPECIFIED |
Approval Year
| Substance Class |
Chemical
Created
by
admin
on
Edited
Mon Mar 31 19:03:33 GMT 2025
by
admin
on
Mon Mar 31 19:03:33 GMT 2025
|
| Record UNII |
R7OYP6N58F
|
| Record Status |
Validated (UNII)
|
| Record Version |
|
-
Download
| Name | Type | Language | ||
|---|---|---|---|---|
|
Preferred Name | English | ||
|
Common Name | English | ||
|
Code | English | ||
|
Common Name | English |
| Code System | Code | Type | Description | ||
|---|---|---|---|---|---|
|
DTXSID9047251
Created by
admin on Mon Mar 31 19:03:33 GMT 2025 , Edited by admin on Mon Mar 31 19:03:33 GMT 2025
|
PRIMARY | |||
|
DB05421
Created by
admin on Mon Mar 31 19:03:33 GMT 2025 , Edited by admin on Mon Mar 31 19:03:33 GMT 2025
|
PRIMARY | |||
|
145742-28-5
Created by
admin on Mon Mar 31 19:03:33 GMT 2025 , Edited by admin on Mon Mar 31 19:03:33 GMT 2025
|
PRIMARY | |||
|
R7OYP6N58F
Created by
admin on Mon Mar 31 19:03:33 GMT 2025 , Edited by admin on Mon Mar 31 19:03:33 GMT 2025
|
PRIMARY | |||
|
9821217
Created by
admin on Mon Mar 31 19:03:33 GMT 2025 , Edited by admin on Mon Mar 31 19:03:33 GMT 2025
|
PRIMARY |
| Related Record | Type | Details | ||
|---|---|---|---|---|
|
TARGET -> INHIBITOR |
SELECTIVE
|
||
|
|
SALT/SOLVATE -> PARENT |
|
| Related Record | Type | Details | ||
|---|---|---|---|---|
|
METABOLITE -> PARENT |
IN EXTENSIVE METABOLIZER HUMAN SUBJECTS
URINE
|
||
|
METABOLITE -> PARENT |
IN EXTENSIVE METABOLIZER HUMAN SUBJECTS
URINE
|
||
|
METABOLITE -> PARENT |
IN EXTENSIVE METABOLIZER HUMAN SUBJECTS
URINE
|
||
|
METABOLITE -> PARENT |
IN EXTENSIVE METABOLIZER HUMAN SUBJECTS
URINE
|
||
|
METABOLITE -> PARENT |
IN EXTENSIVE METABOLIZER HUMAN SUBJECTS
URINE
|
||
|
METABOLITE -> PARENT |
IN EXTENSIVE METABOLIZER HUMAN SUBJECTS
URINE
|
||
|
METABOLITE -> PARENT |
IN POOR METABOLIZER HUMAN SUBJECTS
URINE
|
||
|
METABOLITE -> PARENT |
IN POOR METABOLIZER HUMAN SUBJECTS
FECAL
|
||
|
METABOLITE -> PARENT |
IN TWO EXTENSIVE METABOLIZER HUMAN SUBJECTS
FECAL
|
| Related Record | Type | Details | ||
|---|---|---|---|---|
|
|
ACTIVE MOIETY |
|
| Name | Property Type | Amount | Referenced Substance | Defining | Parameters | References |
|---|---|---|---|---|---|---|
| Biological Half-life | PHARMACOKINETIC |
|
ORAL ADMINISTRATION |
|
||
| Biological Half-life | PHARMACOKINETIC |
|
IN POOR METABOLIZERS |
|
||